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INTRODUCTION 
 
 
                  Surgical site infection (SSI) is the most frequent complication in  
 
inguinal hernioplasty. 
                      
                               Some studies have identified risk factors for SSI such as 
 
 sex (greater in women), age (older than 70 years), co morbidity, operative time,  
 
and routine use of drainage and prostheses.SSI is related with an increase in  
 
length of stay and costs and a decrease in quality of life. In the 1970s, it was  
 
demonstrated that antibiotic prophylaxis for clean-contaminated surgery was the  
 
most cost-effective intervention to prevent SSI. But some authors have  
 
recommended its use in clean procedures as inguinal herniorrhaphy.  
 
                                     However, the recognition of the free tension  
 
herniorrhaphy concept and the current introduction of mesh hernioplasty made  
 
the use of antibiotic prophylaxis more critical because of the infection risk when  
 
prosthetic materials are used. Antibiotic prophylaxis use in patients  
 
submitted to mesh inguinal hernioplasty decreased the rate of surgical site  
 
infection by almost 50%.  
 
                                   To prove the effectiveness of antibiotic prophylaxis in  
 
these procedures, it is necessary to conduct randomized clinical trials (RCTs)  
 
with large numbers of patients, which are difficult and sometimes unfeasible. 
                                        Available evidence related to the effectiveness of  
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antibiotic prophylaxis for mesh inguinal hernia repair is found in a meta- 
analysis, including few RCTs. SSI rate was 1.2% and 3.3%, in the prophylaxis  
and placebo group, respectively (odds ratio = 0.28; 95% confidence interval  
[CI], 0.02–3.        
                                         These results concluded there were no statistical  
differences between groups, so antibiotic prophylaxis was not recommended.  
However, new RCTs including patients with mesh hernioplasty have been  
published in the last years, increasing the number of patients evaluated. 
                                    Antibiotic prophylaxis in inguinal hernia surgery is  
controversial, especially after the increasing use of mesh. For some authors,  
hernia and breast surgery are clear examples of the benefits of antibiotic  
prophylaxis in clean surgery. Others consider that low frequency of SSI in  
hernia surgery does not justify prophylaxis.  
                     A previous meta-analysis by Sanchez-Manuel and Seco-Gil for the  
Cochrane Collaboration, including 8-high quality RCTs, reported no statistical  
difference in SSI rates between antibiotic and no antibiotic groups. However, a  
subgroup analysis suggested that, in mesh hernia repair, a protective effect  
could exist, undetectable because of the small sample size. 
                             The use of prosthetic material for inguinal hernia repair has  
increased dramatically ever since described by Giraud and colleagues using  
Nylon mesh in 1951. Various meshes have since been developed consisting  
mainly of non absorbable materials such as polypropylene, polyester and  
polytetraflouroethylene.  
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                                       The presence of plastic biomaterial increases the  
incidence of complications relating to the mesh itself, in addition to other  
recognized complications of the hernia repair. The most serious complication is  
the development of mesh infection leading to groin sepsis sometimes  
necessitating the removal of mesh implant 
                                   To prevent mesh infection, antibiotic prophylaxis is  
often indicated and recommended. Most surgeons have used prophylactic  
antibiotics for Lichtenstein hernia repair. The true incidence of mesh infection is  
not exactly known because in some series infection rates of 1.9% to 7.5% has  
been reported. 
                                     Use of antibiotics in Lichtenstein’s hernia repair is  
still debatable in government set up. Some surgeons use a single dose of pre- 
operative antibiotic, while the majority use multiple doses of post operative  
antibiotics claiming that the latter is superior to the former in reduction of  
surgical site infection in Lichtenstein s repair 
                                 Another subject in government setup that must be  
addressed in antibiotic prophylaxis is cost-effectiveness. In these cases, the  
costs of antibiotic administration must be carefully evaluated against the  
potentials benefits. Only studies particularly designed to answer this question  
could solve it. This study is intended for the above reasons 
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AIM 
 
 
 
                   To assess the efficacy of single dose pre-operative antibiotic  
 
compared to multiple doses of post-operative antibiotic administration in  
 
reducing  surgical site infection after Lichtenstien repair. 
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OBJECTIVES 
 
 To compare the incidence of surgical site infection in patients receiving  
single dose of pre operative antibiotics with those receiving multiple dose  
of post operative antibiotics in Lichtenstein’s hernioplasty. 
 
 To determine if single dose of pre operative antibiotic is therapeutically  
and cost effectively more beneficial than multiple doses of  
post operative antibiotics in reducing surgical site infection after  
Lichtenstein’s hernioplasty. 
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REVIEW OF LITERATURE 
 
Until the middle of the 19th century, when Ignaz Semmelweis and Joseph Lister 
became the pioneers of infection control by introducing antiseptic surgery, most 
wounds became infected. In cases of deep or extensive infection this resulted in 
a mortality rate of 70-80%. Since then a number of significant developments, 
particularly in the field of microbiology, have made surgery safer. However, the 
overall incidence of healthcare associated infections (HAIs) remains high and 
represents a substantial burden of disease. 
In 1992, the US Centres for Disease Control (CDC) revised its definition of  
'wound infection', creating the definition 'surgical site infection' (SSI) to prevent  
confusion between the infection of a surgical incision and the infection of a  
traumatic wound. Most SSIs are superficial, but even so they contribute greatly  
to the morbidity and mortality associated with surgery. Estimating the cost of  
SSIs has proved to be difficult but many studies agree that additional bed  
occupancy is the most significant factor. A review of the incidence and  
economic burden of SSIs in Europe estimated that the mean length of extended  
stay attributable to SSIs was 9.8 days, at an average cost per day of €325. 
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Wound infections have been subdivided according to the following clinically  
related subgroups  
Aetiology: in a primary infection, the wound is the primary site of infection,  
whereas a secondary infection arises following a complication that is not 
 directly related to the wound; 
Time: an early infection presents within 30 days of a surgical procedure,  
whereas an infection is described as intermediate if it occurs between one and  
three months afterwards and late if it presents more than three months after  
surgery; 
Severity: a wound infection is described as minor if there is discharge without  
cellulitis or deep tissue destruction, and major if the discharge of pus is  
associated with tissue breakdown, partial or total dehiscence of the deep fascial  
layers of the wound, or if systemic illness is present. 
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HEALING BY PRIMARY INTENTION 
 
Surgical wounds may heal by primary intention, delayed primary intention or by  
secondary intention. Most heal by primary intention, where the wound edges are 
 brought together (apposed) and then held in place by mechanical means  
(adhesive strips, staples or sutures), allowing the wound time to heal and  
develop enough strength to withstand stress without support. The goal of  
surgery is to achieve healing by such means with minimal oedema, no serous  
discharge or infection, without separation of the wound edges and with minimal  
scar formation. On occasion, surgical incisions are allowed to heal by delayed 
 primary intention where non-viable tissue is removed and the wound is initially  
left open. Wound edges are brought together at about 4-6 days, before  
granulation tissue is visible . This method is often used after traumatic injury.  
 
HEALING BY SECONDARY INTENTION 
 
Healing by secondary intention happens when the wound is left open, because  
of the presence of infection, excessive trauma or skin loss, and the wound edges 
 come together naturally by means of granulation and contraction . 
Experimentally as well as clinically it has been shown that a delay in wound  
closure of four to five days increases the tensile strength of the wound as well as 
 resistance to infection. The overall rate of SSIs in traumatic war wounds using  
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delayed principles was 3-4%, compared with more than 20% after primary  
closure . In civilian practice, delayed healing has been used successfully in  
cases of severe incisional abscesses, mainly after laparotomy. Another benefit  
of delayed closure is the cosmetic result after healing. The appearance of a  
wound after a delay of four to five days is comparable to that of primary  
closure. A wider scar follows late closure (after 10-14 days), although this is  
cosmetically much better than the result obtained after the healing of an open  
granulating wound. 
Many factors influence surgical wound healing and determine the potential for,  
and the incidence of, infection . The level of bacterial burden is the most 
 significant risk factor, but modern surgical techniques and the use of  
prophylactic antibiotics have reduced this risk. 
A system of classification for operative wounds that is based on the degree of  
microbial contamination was developed by the US National Research Council  
group in 1964 . Four wound classes with an increasing risk of SSIs were 
 described: clean, clean-contaminated, contaminated and dirty.  
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Classification of operative wounds based on degree of microbial 
contamination 
Classification Criteria 
Clean 
Elective, not emergency, non-traumatic, primarily closed;  
 
 no inflammation; no break in technique; respiratory,  
 
gastrointestinal, biliary and genitourinary tracts not 
 
 entered.  
Clean-
contaminated 
Urgent or emergency case that is otherwise clean; elective  
opening of respiratory, gastrointestinal, biliary or  
genitourinary tract with minimal spillage (e.g. 
appendectomy) 
 not encountering infected urine or bile; minor technique  
break.  
Contaminated 
Non-purulent inflammation; gross spillage from  
 
gastrointestinal tract; entry into biliary or genitourinary tract  
 
in the presence of infected bile or urine; major break in  
 
technique; penetrating trauma <4 hours old; chronic open 
 
 wounds to be grafted or covered.  
Dirty 
Purulent inflammation (e.g. abscess); preoperative  
 
perforation of respiratory, gastrointestinal, biliary or  
 
genitourinary tract; penetrating trauma >4 hours old.  
[Adapted from Berard F, Gandon J, Ann Surg 1964 ] 
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DEFINITIONS OF PERIOPERATIVE AND PERIPROCEDURAL  
SURGICAL PROPHYLAXIS 
 
                                 Perioperative prophylaxis implies the use of antibiotics in  
elective surgical procedures in patients without previous signs of inflammation  
or infection aimed at preventing the occurrence of surgical site infection. 
                                 Periprocedural prophylaxis implies the use of antibiotics  
aimed at preventing the spread of infection after invasive diagnostic-therapeutic  
procedures in surgery and other nonsurgical medical areas (e.g. endoscopic  
procedures).  
                                       Primary goal of antimicrobial prophylaxis is to reduce  
microbial contamination in surgical site in order to prevent infection.  
Perioperative and peri procedural prophylaxis are primarily intended for  
prevention of surgical site infections, but not any other infections that may  
occur as a consequence of hospitalization (e.g. hospital acquired pneumonia). 
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Level of recommendation  
 
 
 
Level 
 
Recommendation 
 
 
 
   A 
 
Requires at least one randomized controlled trial as part of a body of  
literature of overall good quality and consistency addressing the  
specific recommendation. (Evidence levels Ia, Ib) 
 
 
   B 
 
Requires the availability of well conducted clinical studies but no  
randomised clinical trials on the topic of recommendation.  
(Evidence levels IIa, IIb, III) 
 
 
 
   C 
 
Requires evidence obtained from expert committee reports or opinions  
And/or clinical experiences of respected authorities. Indicates an 
 absence of directly applicable clinical studies of good quality.  
(Evidence level IV) 
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RISK FACTORS FOR SURGICAL SITE INFECTIONS 
 
GENERAL AND LOCAL RISK FACTORS 
 
Antimicrobial perioperative prophylaxis should be applied in patients with  
increased risk for infection due to general or local risk factors which are listed  
in Table
. 
Factors associated with an increased risk of surgical site infection 
 
Systemic factors Local factors 
 
Diabetes 
 
Foreign body 
 
Corticosteroid use 
 
Electrocautery 
 
Obesity 
 
Injection with epinephrine 
 
Extremes of age 
 
Hair removal with razor 
 
Malnutrition 
 
Previous irradiation of surgical site 
 
Recent surgery 
 
 
 
Massive transfusion 
 
 
Multiple (3 or more) preoperative co  
morbid medical diagnoses 
 
 
ASA class 3, 4 or 5 
 
 
22 
 
 
 
RISK ASSOCIATED WITH ASA CLASS 
 
  According to the preoperative risk score devised by the American Society of  
Anaesthesiologists (ASA), the risk for wound infection is associated with  
general assessment of the patient`s physical status. 
 
ASA CLASSIFICATION OF THE PATIENT`S PHYSICAL STATUS: 
 
1 – Normal healthy patient, 
2 – Patient with a mild systemic disease, 
3 – Patient with a severe systemic disease that limits activity, but is not 
incapacitating, 
4 – Patient with an incapacitating systemic disease that is constant threat to 
life, 
5 – Moribund patient not expected to survive 24 hours with or without 
operation.   
 
If ASA score >2, the risk for wound infection is increased. 
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     Risk associated with the type of surgical procedure 
 
 An increased risk for the development of surgical site infection is  
described in the chapter Classification of surgical procedures. 
 
     Risk associated with the insertion of prosthetic implants 
 
 Insertion of any type of prosthetic implants increases the risk for 
infection.  
 
 
     Risk associated with the duration of surgery 
 
 The risk for surgical site infection is directly proportional to the duration 
of   surgical procedure. 
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           COMMON SURGICAL SITE INFECTION PATHOGENS  
 
                                   The majority of surgical site infections are caused by  
bacteria the patient is colonized with and are part of the normal human flora.  
Exceptionally, in patients with prolonged hospital stay, multiple resistant  
hospital pathogens can be expected. 
 The most common bacterial pathogens causing surgical site infections  
 
 Staphylococcus aureus 
 Coagulase-negative staphylococci (CONS) 
 Enterococcus spp. 
 Escherichia coli 
 Pseudomonas aeruginosa 
 Enterobacter spp. 
 Proteus mirabilis 
 Klebsiella pneumoniae 
 Streptococci 
 Candida albicans 
.  
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CLASIFICATION OF SURGICAL SITE INFECTIONS 
 
 
Superficial incisional SSI - occur within 30 days after the operation; involve  
Skin and subcutaneous tissue of the incision and at least one of the following  
signs :  
     1. Purulent drainage,  
    2. Organism isolated from an aseptically obtained culture,  
         3. At least one of the following symptoms:  
             Pain,  
            Swelling, 
            Redness, 
            Heat. 
Deep incisional SSI – occur within 30 days after the operation (within 1 year if  
implant is in place), involve deep soft tissue of the incision, and at least one of  
the following signs:  
1. Purulent drainage from the deep incision (but not from the organ/space 
component of the surgical site) 
2. Spontaneous dehiscence or is deliberately opened by a surgeon when the 
patient has at least one of the following signs or symptoms:  
      Fever, localized pain,   redness,   heat. 
3.  An abscess 
 The diagnosis of superficial infection is made by surgeon of supervising 
physician.  
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Organ/space SSI - occur within 30 days after the operation (within 1 year if  
implant is in place), involve organs or spaces exposed to operation with at least  
one of the following:  
 
1.      Purulent discharge from a drain that is placed into the organ/space 
2.      Organism isolated from an aseptically obtained culture of tissue or fluid in   
         the organ/space   
3.      An abscess found on direct examination, during reoperation or according  
         to radiologic or Histopathological finding . 
 
If an infection involves tissues  below deep fascia , it should be treated  
as deep incisional infection. If an organ space infection is drained  
through incision it should be treated as  organ space  infection. 
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ANTIBIOTICS IN SURGICAL PROPHYLAXIS 
 
                               The antibiotic chosen for prophylaxis should cover the most  
common SSI pathogens, however not necessarily all possible pathogens.  
                             The choice of antibiotic primarily depends on anatomic  
location of the surgical procedure. Also, the antibiotic used in prophylaxis  
should differ from other drugs used in the therapy for the same anatomic area in  
order to prevent the development of resistance and preserve those medications  
efficient for the treatment of infections in a particular anatomic area 
                             If a contamination with anaerobic pathogens is possible, e.g.  
during colorectal, gynaecological and head and neck procedures, the use of  
antibiotic with  anaerobic activity is recommended.    
                            If a patient is already receiving an antibiotic that covers  
targeted organisms for that particular surgical procedure, prophylaxis is not  
needed. 
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ROUTE OF ANTIBIOTIC ADMINISTRATION 
 
Intravenous administration of prophylactic antibiotic is recommended.  
This route of antibiotic administration can achieve necessary concentration  
of   drug in blood and tissues during surgical procedure. 
The absorption of drug after oral or intramuscular administration varies  
individually. 
 
 
TIMING OF ANTIBIOTIC ADMINISTRATION 
 
 Antibiotic should optimally be given half an hour before incision, when             
the  patient has stabilized after anaesthesia induction.  
 
 Vancomycin should be given in a slow infusion which should terminate  
one  hour before incision, that is, the infusion should start within 3 hours  
from incision.  
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DURATION OF PROPHYLAXIS 
 
 A critical period for the development of surgical site infections is 4 hours  
from bacterial entrance into the wound. 
 Perioperative antimicrobial prophylaxis has to ensure an optimal drug  
concentration in the plasma and extracellular fluid of potentially 
contaminated tissues during the procedure itself and for several hours  
after wound closure. 
 One dose of antibiotic   ½ hour before skin incision is considered  
sufficient . The administration of an additional dose of antibiotic should  
be Considered  if the procedure lasts longer than the double antibiotic half  
life (T1/2)  
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ANTIBIOTIC DOSAGE 
 
 The dose of antibiotic for prophylaxis is in most circumstances the same 
as it would be use in therapy.  
 
 Antibiotic dose should be proportional to the patient`s body mass index,  
i.e. the patient`s weight. 
 
 Studies in patients over 85 kg have indicated the need for a double dose 
in perioperative prophylaxis in order for drug concentrations in blood and  
tissues to be above the minimal inhibitory concentration.
 
 
BLOOD LOSS, FLUID REPLACEMENT AND ANTIBIOTIC 
PROPHYLAXIS
 
 
 In adult patients, the influence of blood loss or fluid replacement on  
serum concentration of the prophylactic drug is negligible.  
 
 An additional dose of prophylactic antibiotic should be given if blood 
loss is greater than 1500 ml, or haemodilution is up to 15 ml/kg. 
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                              RISKS OF ANTIBIOTIC PROPJYLAXIS 
 
 Even proper use of antibiotics in perioperative prophylaxis increases the  
incidence of Clostridium difficile colitis.
  
 
 Antimicrobial prophylaxis in surgery can influence the resistance of 
bacteria to antibiotics.
  
 
 There is always a risk of  drug allergy 
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PREVENTIVE TECHNIQUES 
The surgical technique used can affect the infection rate in various ways, for 
 example in relation to skin preparation, shaving and wound closure. 
Skin preparation: The skin is colonised by various types of bacteria, but up to  
50% of these are Staphylococcus aureus[14]. In analyses of contamination rates  
after cholecystectomy, the main source of wound contamination was found to  
be the skin of the patient [15]. For this reason, preoperative preparation should  
be performed. Evidence has shown that the use of a preoperative wash  
containing chlorhexidine decreases the bacterial count on skin by 80-90%,  
resulting in a decrease in preoperative wound contamination [16]. The effect on  
SSI incidence has, however, been more difficult to demonstrate and it is  
possible that prolonged washing releases organisms from deeper layers of the  
skin. 
Shaving: It is now recognised that shaving damages the skin and that the risk of  
infection increases with the length of time between shaving and surgery [10]. In  
one study, if the patient had been shaved more than two hours before surgery  
the clean wound infection rate was found to be 2.3% [11]. However, if patients  
had not been shaved but their body hair had been clipped the rate was 1.7%, and  
if they had not been shaved or clipped the rate dropped to 0.9%[11]. If shaving  
is essential, it should be performed as close to the time of surgery as possible. 
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MATERIALS AND METHODS 
   
DESIGN 
 
 
A prospective Randomised control study 
                
COLLECTION OF DATA AND SOURCES 
 
 The study was conducted in Coimbatore Medical College  
Hospital from 2007 to 2010. 
 The population for the study were from surgical units in 
CMCH.  
 The results were tabulated and appropriate tests of significance  
were worked up. 
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INCLUSION CRITERIA 
 
 
 Patients with primary inguinal hernia in age group 30 to 65 yrs 
 
 Patients with primary inguinal hernia in age group 20 to 30 yrs  
 
with weak abdominal musculature who were ineligible for  
 
herniorrhaphy. 
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EXCLUSION CRITERIA 
 
 
Patients with 
 
 Recurrent hernias,  
 
 Immunosuppressive diseases, 
 
 Allergies for the given antibiotic, 
  
 Prior infection,  
 
 Patients who had received antibiotics within past 48 hours, 
 
 Pregnant and lactating women, 
 
 Patients with cardiac valvular disease, prosthetic valves, 
 
 Patients with uncontrolled DM and HT. 
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GROUP SELECTION 
 
Patients under the inclusion criteria were arranged randomly into two  
groups A and B. 
 Group A received 1 gram of Cefotaxime just before skin incision. 
 
 Group B received 1 gram Cefotaxime twice daily post operatively for 5 
days. 
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PRE-OPERATIVE PREPARATION 
 
 Standard aseptic precautions as for any other surgery. 
 
 All diabetic patients had strict glycemic control and 
 
 Normal FBS and urine acetone negative before surgery. 
 
OPERATIVE PROCEDURE 
 
 All the patients were operated in same theatre. 
 
 Pre-operative preparation of the surgical site done according to standard  
     principles. 
 Lichtenstein’s repair was done in all patients. 
 
 Dressing done after surgery. 
 
 Surgical site inspected after 48 hours.  
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Follow up 
The surgical site was inspected daily from second post operative day onwards  
based on the following criteria for SSI. 
 
Surgical site infection surveillance criteria 
 
 Presence of purulent drainage 
 
 Presence of erythema and drainage 
 
 Erythema extending at least 2 cm beyond the wound edges 
 
 A wound that was opened and left to heal by secondary 
intention. 
 
 Wound dehiscence. 
 When there was no SSI sutures were removed on the 7
th
 post operative day and  
the patient was discharged. In patients who had SSI, culture and sensitivity tests                                        
were done and appropriate antibiotics were given.  A patient with wound gaping  
had thorough wound debridement and secondary suturing was done. 
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DATA COLLECTION AND ANALYSIS 
 
The following data were collected and analysed. 
1. Patients demographic profile 
2. Clinical type of hernia (direct / indirect) 
3. Biochemical parameters 
4. Anaesthesia variables such as  
 ASA grade 
 Type of anaesthesia  
 Duration of anaesthesia 
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STATISTICAL ANALYSIS 
 
 Analysis of the data was done with primary objective to determine if 
          single dose of pre operative antibiotic is therapeutically and cost 
         effectively more beneficial than those receiving multiple dose of post 
         operative antibiotics in reducing surgical site infection after 
          Lichtenstein’s repair. 
 
 Differences between groups in the distribution of parameters were tested  
using chi -square test and p<0.05 was considered statistically significant. 
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SURGICAL SITE SINGLE DOSE MULTIPLE DOSE Total 
Infected 1 4 5 
Not infected 56 54 110 
Total 57 58 115 
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TYPE OF HERNIA  
 
 
Type of hernia  
 
 
Group A 
 
Group B 
 
Direct  
 
26 
 
25 
 
Indirect  
 
31 
 
33 
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AGE WISE DISTRIBUTION OF PATIENTS 
  
 
 
Age of the patient in 
years 
 
Group A 
 
Group B 
 
20-30 
 
2 
 
1 
 
31-40 
 
16 
 
18 
 
41-50 
                   
                  14 
 
12 
 
51-60 
                   
                   15 
 
14 
 
61-65 
 
10 
 
13 
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                         AGE WISE DISTRIBUTION OF SSI 
 
 
Age of the patient in 
years 
 
Group A 
 
Group B 
20-30 Nil Nil 
31-40 Nil Nil 
41-50 Nil Nil 
51-60 one Two 
61-65 Nil Two  
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SEX WISE DISTRIBUTION OF PATIENTS 
 
 
 
 
 
Sex 
 
Group A 
 
Group B 
 
Males 
 
56 
 
58 
 
 
Females  
 
1 
 
NIL 
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CO-MORBID CONDITIONS 
 
 
 
Co-morbid conditions 
       
       Group A 
 
Group B 
 
Diabetes mellitus 
 
12 
 
10 
 
Hypertension  
 
6 
 
4 
 
Malnutrition  
               
                 Nil  
 
Nil  
 
 
 
      
 
47 
 
 
  
SSI 
 
 
 
 
 
 
 
 
 
              
 
 
 
 
 
Total cases 
 
SSI present 
 
57 
 
1  
 
Total cases 
 
SSI present 
 
58 
 
4 
48 
 
 
 
ASA GRADE DISTRIBUTION 
 
 
           ASA grade 
 
Group A 
 
Group B 
1 26 22 
2 21 23 
3 10                    13  
4 Nil  Nil  
5 Nil  Nil  
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ASA GRADE AND SSI 
 
 
ASA grade 
 
Group A 
 
Group B 
1 Nil  Nil  
2 Nil  1 
3 1  3 
4 Nil  Nil  
5 Nil  Nil  
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TYPE OF ANAESTHESIA 
 
 
 
 
Type of anaesthesia 
 
 
Group A 
 
 
Group B 
 
Spinal  
 
56 
 
58 
 
Epidural 
 
Nil  
 
Nil  
 
General  
 
1 
 
Nil  
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DURATION OF SURGERY  
 
 
 
Duration of surgery  
 
 
       
Group A 
 
 
Group B 
<30 min 14 13 
30-40 min 12 9 
40-50 min 27 33 
> 50 min 4 3 
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DURATION OF SURGERY AND SSI 
 
 
Group 
 
<30 min 
 
30-40 min 
 
40-50 min 
 
> 50 min 
A Nil  Nil  Nil  One  
 
B 
 
Nil  
 
Nil  
 
Two  
 
Two  
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CHARACTERISTICS OF SSI PATIENTS 
 
 
S 
NO 
 
GROUP  
 
AGE  
 
SSI 
DETECTED 
ON POD  
 
TYPE OF SSI 
 
ORGANISM  
 
1 
 
A  
 
52 
 
4 
 
Purulent  
 
KLEBSIELLA 
 
2 
 
B 
 
55 
 
3 
 
Purulent  
 
E. COLI 
 
3 
 
B  
 
57 
             
            4 
 
Fever /serous 
 
NIL 
 
4 
 
B 
 
60 
 
4 
          
         Fever/erythema  
 
NIL 
 
5 
 
B 
 
63 
 
5 
 
Wound gaping 
 
STAPHYLOCOCCUS 
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CALCULATION 
 
  
 Null hypothesis: There is no significant difference in infection rates 
between pre-operative and post-operative administration of antibiotics. 
 
 Alternate hypothesis: Pre-operative antibiotic administration results in 
significantly lower infection rates. 
 
 X2 = € ((O-E) 2/E) 
 Expected value E= (row total x column total)/overall total 
 E1= (57 x 5)/115 = 2.48 
 E2= (58 x 5)/115 = 2.52 
 E3= (57 x 110)/115 = 54.52 
 E1= (58 x 110)/115 = 55.47 
 X2 = (1.48^2)/2.48 + (1.48^2)/2.52 + (1.48^2)/54.52 + (1.48^2)/55.47 
 X2   = 0.88+0.04+0.87+0.04 
 X2  = 1.83 
 Value of X2 is less than value of X2 at degree of freedom 1 at 0.05 
level(3.84) 
 Thus, null hypothesis is true. 
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OBSERVATIONS AND RESULTS 
 
115 patients were recruited to the study from AUGUST 2007 to 
OCTOBER 2009. 
Patients were assigned randomly into two groups A(n=57) and 
B(n=58),to receive  single dose or multiple dose antibiotics respectively. 
The baseline characteristics were similar in both groups. 
There was no statistically significant age specific infection risk. 
Type of anaesthesia, and ASA grade were similar in both groups. 
Duration of procedure was almost 50 minutes to 1 hour in all the patients. 
SSI was identified on the 3
rd
 to 5
th
 post operative day in both groups. 
Bacteria isolated were Klebsiella, staphylococcus and E.coli  
Incidence of SSI in group A was 2 %( 1 among 57patients) 
Incidence of SSI in group B was 6 %( 4 among 58 patients)  
Incidence of SSI though higher in group B than group A was not statistically  
significant when chi square test was applied. 
Incidence of SSI was higher in both the groups with high ASA Grades and  
prolonged duration of surgery. 
The cost of antibiotic per patient in group A was Rs.14 while that in group B  
was between a minimum of Rs.140 in patients without SSI to a maximum of  
Rs.650 with SSI.  
The difference in cost of antibiotic in both groups was statistically  
significant. 
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DISCUSSION 
 
Inguinal hernia is the commonest problem amongst all external hernias and 
 inguinal hernia repair is most frequent procedure in general surgery 
 accounting for 10–15% of all operations. The age incidence is distributed in 
 all decades of life. Incidence of inguinal hernia is race related. It is at least  
three times more common in black Africans than in the white population. 
                                             About 80–90% of repairs are done in males. The   
most frequent type is right sided indirect inguinal hernia. Direct inguinal  
hernias are rare in females.  
                                             Due to its common nature and increased  
incidence of recurrence and wound infection, a wide variety of surgical  
procedures and different materials were being used from time to time for  
hernia repair. 
                                             All these procedures and materials have  
equivocal results and are beyond the level of satisfaction for different  
surgeons. All these modifications and surgical techniques have showed a  
common disadvantage i.e. suture line tension, which leads to increased  
incidence of recurrence and other complications.  
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     Post operative wound infection remains a common complication after  
hernia repair. 
                                       With the use of modern mesh prosthesis, it is now  
possible to repair all hernias without distortion of the normal anatomy and  
with no suture line tension. 
                                     Modern mesh is strong monofilament, inert, and  
readily available. It is unable to harbour infection, is very thin and porous. Its  
interstices become completely infiltrated with fibroblasts and remain strong  
permanently .It is not subjected to deterioration or rejection or it cannot be  
felt by patients or surgeons postoperatively.
 
                                          Many factors including antimicrobial prophylaxis  
affect surgical site infection. For eg., beginning antibiotic prophylaxis during  
the immediate preoperative period reduces the risk of wound infection  
fourfold. Maintaining therapeutic antibiotic levels in the serum and tissues  
throughout the operation until, at most, a few hours after incision closure  
reduces this risk. 
                                           In this study, patients in Group A received a  
single dose of Inj. Cefotaxime 1 g at induction time and patients in Group B  
received multi dose of Inj. Cefotaxime 1 g, twice daily for 5 days 
                                               Indiscriminate use of antibiotics leads to  
proliferation of resistant organisms and was probably responsible for high  
rate of surgical site infection of 6% in Group B when compared with group  
A 2%.  Pathogens encountered in these patients were E.coli/Staph/ Klebsiella  
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CONCLUSION 
 
 Single dose antibiotic prophylaxis was therapeutically efficient as well as  
cost effective in comparison with multiple doses of postoperative antibiotics  
usage for the prevention of surgical site infection in uncomplicated elective  
cases of Lichtenstein’s hernioplasty. The infection rate is less when compared to 
 studies wherein no antibiotics were used. The study shows that the cost of  
management of hernia patients with respect to use of antibiotics can be reduced 
 in Govenment set up by use of single dose antibiotic, thereby reducing financial 
 burden to the Government. 
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                     Proforma               case no: 
 
 
Study group:   Single dose pre- op  ( A )   / Multiple doses post-op  ( B ) 
 
 
Name:                                                                    age/ sex:                                          
 
I.P.No 
 
Diagnosis:                                                                     
 
 
Investigations 
 
 
Date of admission:                                    Date of surgery:                                       
Date of discharge: 
 
Wound infection:      Yes / No 
 
                                                                  If yes, type 
 
Erythema 
 
Serous 
discharge 
 
Purulent 
discharge 
 
Wound 
dehiscence 
 
Mesh 
exposed 
 
Fever 
 
                                                           
                                                         Culture sensitivity  
 
Organism isolated 
 
Antibiotic sensitivity 
 
Antibiotic ,Dose and 
duration 
   
 
 
                                                 Outcome of the case                         
 Wound uninfected                                                                    Wound infected     
 
 
 
 
 
Hb% 
 
Glucose 
 
Urea 
 
Creatinine 
 
Others(specify) 
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DEEP SURGICAL SITE INFECTION 
 
 
 
 
                  
    
 
              DEEP SSI- 5
TH
 POD                                   DEEP SSI- 9
TH
 POD 
 
 
 
                                            
 
 
                                                 DEEP SSI- 14
TH
 POD 
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WOUND CLOSURE 
 
 
 
 
                         
 
          
           STAPLERS                                                              SILK 
 
 
 
 
 
 
 
PROLENE 
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TYPES OF SSI 
 
 
 
 
 
                      
 
            ERYTHEMA                                         SEROUS DISCHARGE 
 
 
 
 
 
                  
 
 
     PURULENT DISCHARGE                              WOUND GAPING 
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GROUP A- SINGLE DOSE  
S.NO NAME AGE/SEX 
IP 
NO 
TYPE OF 
SSI ORGANISM 
INGUINAL HERNIA 
1 RAMESH 38/M 37623 (R) DIRECT NIL 
 
2 VISHWANATHAN 70/M 39041 (R) INDIRECT NIL 
 
3 KARUPATHAL 72/F 39180 (L) DIRECT NIL 
 
4 SELVARAJ 42/M 39214 (R) INDIRECT NIL 
 
5 RADHAKRISHNAN 46/M 41563 (L) INDIRECT NIL 
 
6 RAJA 52/M 40424 (R) INDIRECT NIL 
 
7 SAGADEVAN 56/M 45972 (L) INDIRECT NIL 
 
8 MUTHU 63/M 47524 (R) DIRECT NIL 
 
9 CHINNATHURAI 37/M 48624 (L) INDIRECT NIL 
 
10 ARUNGAJ 48/M 50052 (R) INDIRECT NIL 
 
11 MAKALI 50/M 50060 (R) INDIRECT NIL 
 
12 ARUNACHALAM 58/M 51526 (L) DIRECT NIL 
 
13 RAMU 40/M 56041 (L) DIRECT NIL 
 
14 SUNDARAM 46/M 61200 (L) INDIRECT NIL 
 
15 SIVAKUMAR 41/M 61820 (R) INDIRECT NIL 
 
16 MANI 67/M 68137 (R) DIRECT NIL 
 
17 MADHAVAN 35/M 68202 (L) INDIRECT NIL 
 
18 CHINNARAJ 55/M 69511 (L) INDIRECT NIL 
 
19 ARIVALAGAN 37/M 60940 (R) INDIRECT NIL 
 
20 NATRAJ 52/M 68934 (R) INDIRECT NIL 
 
21 RAVIKUMAR 37/M 61121 (R) INDIRECT NIL 
 
22 MANO 35/M 60469 (R) INDIRECT NIL 
 
23 RAMAN 60/M 42947 (R) DIRECT PRESENT KLEBSIELLA 
24 ANGAMMAL 49/F 68962 (L) INDIRECT NIL 
 
25 NATARAJ 52/M 68934 (R) INDIRECT NIL 
 
26 MUNYAMUTHU 60/M 66171 (R) DIRECT NIL 
 
27 VELUMURUGAN 69/M 66107 (R) DIRECT NIL 
 
28 PALANISAMY 54/M 55503 (R) DIRECT NIL 
 
29 SELVARANI 32/F 51791 (L) INDIRECT NIL 
 
30 MANICHAM 42/M 41804 (L) INDIRECT NIL 
 
31 BALASUBRAMANIAM 35/M 53296 (R) INDIRECT NIL 
 
32 KARTHIKEYAN 45/M 65226 (R) INDIRECT NIL 
 
33 MANSUR 33/M 25333 (L) INDIRECT NIL 
 
34 KALIMUTHU 49/M 27641 (R) INDIRECT NIL 
 
35 LAKSHMANAN 43/M 27626 (R) INDIRECT NIL 
 
36 PONNUSAMY 65/M 37669 (R) DIRECT NIL 
 
37 THANGAMUTHU 44/M 37667 (R) INDIRECT NIL 
 
38 PETER 75/M 40339 (R) DIRECT NIL 
 
39 MARUTHACHALAM 39/M 45841 (L) INDIRECT NIL 
 
40 SATHAPPAN 37/M 53061 (L) INDIRECT NIL 
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41 DEVARAJ 40/M 53063 (R) INDIRECT NIL 
 
42 UDAYARAJ 33/M 41052 (R) INDIRECT NIL 
 
43 KARTHIKEYAN 53/M 40072 (R) DIRECT NIL 
 
44 MANICHAM 37/M 41221 (R) INDIRECT NIL 
 
45 PALANISAMY 48/M 41814 (L) DIRECT NIL 
 
46 RAJENDRAN 34/M 43144 (L) INDIRECT NIL 
 
47 BADRUDEEN 39/M 48294 (L) INDIRECT NIL 
 
48 PERUMAL 39/M 48470 (L) INDIRECT NIL 
 
49 RAJENDRAN 48/M 48222 (R) DIRECT NIL 
 
50 JOHN 59/M 52032 (R) DIRECT NIL 
 
51 KARUPPASAMY 48/M 52593 (R) DIRECT NIL 
 
52 FASEED 65/M 55558 (L) DIRECT NIL 
 
53 PERUMAL 58/M 63211 (R) INDIRECT NIL 
 
54 RAVI 31/M 54230 (L) INDIRECT NIL 
 
55 SIVAKUMAR 66/M 60233 (L) DIRECT NIL 
 
56 KARUPASSAMY 31/M 47064 (L) INDIRECT NIL 
 
57 VEERAPPAN 38/M 47016 (R) INDIRECT NIL 
 
 
 
GROUP B MULTIPLE DOSE 
S.NO NAME AGE/SEX 
IP 
NO 
TYPE OF 
SSI ORGANISM 
INGUINAL HERNIA 
1 GANESAN 63/M 45967 (R)  DIRECT NIL 
 
2 KUPPUSAMY 37/M 50982 (L) INDIRECT NIL 
 
3 CHANDRAN 43/M 50996 (L) INDIRECT NIL 
 
4 BALAKRISHNAN 30/M 50976 (R) INDIRECT NIL 
 
5 NATARAJAN 48/M 52448 (L) INDIRECT NIL 
 
6 VIMAL 34/M 53847 (R) INDIRECT NIL 
 
7 CHINNASAMY 68/M 56711 (L) DIRECT NIL 
 
8 RAJAN 48/M 66876 (R) INDIRECT PRESENT E.COLI 
9 VENKATACHALAM 65/M 58417 (L) DIRECT NIL 
 
10 KANDASAMY 49/M 58401 (R) INDIRECT NIL 
 
11 CHINNASAMY 56/M 59107 (L) DIRECT NIL 
 
12 MUNIYAPPAN 51/M 66222 (R) DIRECT NIL 
 
13 RAMASAMY 65/M 69154 (L) DIRECT NIL 
 
14 KASI VISHWANATHAN 45/M 69391 (L) INDIRECT NIL 
 
15 RAJAKADHAM 65/M 55291 (R) DIRECT NIL 
 
16 NAGARAJAN 65/M 36928 (R) DIRECT PRESENT S. AUREUS 
17 NELLAMEGAM 42/M 69651 (L) INDIRECT NIL 
 
18 JAGADEESAN 39/M 51144 (L) INDIRECT NIL 
 
19 SANTHOSH 38/M 60182 (R) INDIRECT NIL 
 
20 VELUSAMY 55/M 53211 (R) DIRECT NIL 
 
21 AYAARU 56/M 51729 (L) DIRECT NIL 
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22 DORAIRAJ 38/M 21420 (R) INDIRECT NIL 
 
23 PALANIVEL 39/M 22779 (R) INDIRECT NIL 
 
24 MUTHAIYAA 57/M 24151 (R) DIRECT NIL 
 
25 NANJAPPAN 77/M 24627 (L) DIRECT NIL 
 
26 KARTHIKEYAN 33/M 27043 (R) INDIRECT NIL 
 
27 YUNNI 64/M 27076 (L) DIRECT NIL 
 
28 KITTAN 60/M 29860 (R) DIRECT NIL 
 
29 MARIMUTHU 56/M 52821 (L) DIRECT NIL 
 
30 VELUSAMY 53/M 36596 (R) DIRECT NIL 
 
31 NATARAJAN 70/M 60621 (L) DIRECT PRESENT 
 
32 MANICKAM 32/M 35598 (R) INDIRECT NIL 
 
33 NACHIMUTHU 65/M 53241 (L) DIRECT NIL 
 
34 PALANI 80/M 35556 (R) DIRECT NIL 
 
35 SUBRAMANI 46/M 33328 (R) INDIRECT NIL 
 
36 SHANMUGAM 45/M 39972 (L) INDIRECT NIL 
 
37 THANGARAJ 52/M 41239 (R) DIRECT NIL 
 
38 PRASANTH 31/M 41281 (R) INDIRECT NIL 
 
39 KARUPUSAMY 50/M 38557 (L) DIRECT NIL 
 
40 ARUMUGAM 60/M 41246 (R)  DIRECT NIL 
 
41 PALANISAMY 75/M 41254 (L) DIRECT NIL 
 
42 MARIMUTHU 65/M 56421 (L) DIRECT PRESENT 
 
43 VADIVEL 34/M 69761 (R) DIRECT NIL 
 
44 DEVARAJ 39/M 69901 (R) INDIRECT NIL 
 
45 RAMASAMY 54/M 56602 (L) DIRECT NIL 
 
46 ASARAF 38/M 67004 (R) INDIRECT NIL 
 
48 MUNUSAMY 37/M 58216 (R) INDIRECT NIL 
 
49 MYILSAMY 55/M 51124 (R) DIRECT NIL 
 
50 MARIYAPPAN 60/M 51472 (R) DIRECT NIL 
 
51 SARANANGAM 33/M 63421 (L) INDIRECT NIL 
 
52 MANI 63/M 51762 (R) DIRECT NIL 
 
53 MURUGAVEL 43/M 62738 (R) INDIRECT NIL 
 
54 SUNDARAM 55/M 62017 (R) DIRECT NIL 
 
55 ALLIE 72/M 61170 (L) DIRECT NIL 
 
56 SHANMUGAM 63/M 52921 (R) DIRECT NIL 
 
57 SWAMINATHAN 56/M 43281 (L) INDIRECT NIL 
 
58 SURYA 31/M 63281 (R) INDIRECT NIL 
 
 
 
 
 
 
